Despite winning an FDA green light nearly three months ago for its first wearable insulin delivery system, Embecta is now ...

Embecta announced today that it discontinued its insulin patch pump program and plans to initiate a restructuring plan.

Kurdikar, CEO of Embecta (EMBC) said, “As our stand-up work nears completion and following an in-depth review of our ...

Florida mom Kelsey Glover, who was arrested after her 14-year-old daughter was found dead in a bathtub, has been charged with ...

Newly released documents detail the horrifying final days of a 14-year-old girl who died after her mother, identified as ...

Abbott modified its original FreeStyle Libre 2 for the purpose of integration with automated insulin delivery systems. It ...

On Tuesday, Embecta Corp (NASDAQ:EMBC) posted the fourth-quarter adjusted EPS of 45 cents, beating the consensus of 36 cents ...

Recently, CGMs have become available to consumers who do not have a diabetes diagnosis as a way to track blood sugar. Perhaps ...

CEO Dev Kurdikar said the decision may “come as a surprise” as Embecta just received FDA clearance for a patch pump, but the company “did not intend to do a full market launch of this product.” ...

The InPen app paves the way for the launch of the company’s “Smart MDI” system combining a smart insulin pen that tracks ...

Leerink Partners analyst Mike Kratky maintained a Buy rating on Insulet (PODD – Research Report) on November 25 and set a price target of ...